Real-life impact on antimicrobial prescription of Syndromic Molecular Testing in adults hospitalized in infectious disease departments. Respiratory Syndromic Molecular Testing panel: Is it worth it?
-
Published:2024-08
Issue:5
Volume:54
Page:104933
-
ISSN:2666-9919
-
Container-title:Infectious Diseases Now
-
language:en
-
Short-container-title:Infectious Diseases Now
Author:
Clauss Séverine,
Bourlet Stéphane,
Jaffal Karim,
Duran Clara,
D’Anglejan Emma,
Perronne Véronique,
Bouchand Frédérique,
Noussair Latifa,
Dahmane Lotfi,
Dinh AurélienORCID
Reference19 articles.
1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1545–602. DOI: 10.1016/S0140-6736(16)31678-6.
2. GBD 2015 LRI Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis 2017;17:1133–61. DOI: 10.1016/S1473-3099(17)30396-1.
3. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Troeger;Lancet Infect Dis,2018
4. Community-Acquired Pneumonia Requiring Hospitalization among U.S;Jain;Adults New England Journal of Medicine,2015
5. Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study;Webb;Eur Respir J,2019